MGD011, A CD19 x CD3 Dual-Affinity Retargeting Bi-specific Molecule Incorporating Extended Circulating Half-life for the Treatment of B-Cell Malignancies

Liqin Liu(Xinjiang Agricultural University), Ezio Bonvini(MacroGenics (United States)), Syd Johnson(MacroGenics (United States)), Vatana Long(MacroGenics (United States)), Sergey Gorlatov(MacroGenics (United States)), Chia‐Ying K. Lam(MacroGenics (United States)), Lusiana Widjaja(MacroGenics (United States)), Scott Koenig(MacroGenics (United States)), Margaret D. Lewis(MacroGenics (United States)), Hua Li(Fujian University of Traditional Chinese Medicine), Steve Burke(MacroGenics (United States)), Linda X. Jin(MacroGenics (United States)), Ralph Alderson(MacroGenics (United States)), Jeffrey L. Nordstrom(MacroGenics (United States)), Jennifer G. Brown(MacroGenics (United States)), Yinhua Yang(MacroGenics (United States)), Paul A. Moore(Zymeworks (Canada))
Clinical Cancer Research
September 23, 2016
Cited by 69


Related Papers